Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,775,754) $ (2,730,589)
Adjustments to reconcile net loss to cash provided by (used in ) in operating activities:    
Depreciation 2,517 2,517
Stock based compensation 1,003,840 50,300
Amortization of prepaid insurance 65,674 63,342
Amortization of debt discount 998,736 454,629
Amortization of intangible assets 9,475 0
Loss on extinguishment of Debt 114,723 0
Changes in operating assets & liabilities:    
Increase in prepaid expenses (6,758) 0
Increase in prepaid insurance (101,439) (85,000)
Decrease in inventory 5,373 21,919
Increase in due to First Insurance Funding 23,186 21,412
Increase in accounts payable and accrued expenses (142,814) 142,618
Increase in Security Deposits 0 (7,440)
Net cash used in operating activities (3,803,241) (2,066,292)
CASH FLOW FROM FINANCING ACTIVITIES:    
Proceeds from due to shareholders 407,500 0
Repayment of related party loan 0 (5,543)
Repayment of convertible notes (1,965,609) 0
Proceeds from loans receivable 0 500,000
Proceeds from convertible notes 0 3,940,000
Common stock issued under registration statement on Form S-3 3,335,732 0
Common stock issued per stock purchase agreement 600,000 0
Net cash provided by financing activities 2,377,623 4,434,457
Net increase in cash and cash equivalents (1,425,618) 2,368,165
Cash and cash equivalents at beginning of period 2,057,843 713,346
Cash and cash equivalents at end of period 632,225 3,081,511
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Interest 349,169 5,522
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Common stock issued against common stock to be issued 15,000 20,064
Common stock issued against conversion of debt and interest 803,267 199,500
Debt discount and initial derivative liability at issuance of note $ 0 $ 1,320,000